Janneke Verloop

1.6k citations
29 papers · 832 · h-index 12

Impact in

  • Urology top 5%
    • Urological Disorders and Treatments
  • Oncology top 10%
    • Cancer Risks and Factors
    • Cancer survivorship and care
    • COVID-19 and healthcare impacts
    • Global Cancer Incidence and Screening

Papers in

  • Oncology 14
    • Cancer Risks and Factors 6
    • Cancer survivorship and care 6
    • Global Cancer Incidence and Screening 3
    • COVID-19 and healthcare impacts 1
  • Cancer Research 6
    • Breast Cancer Treatment Studies 6
Co-authors
Flora E. van Leeuwen (5 shared papers)Matti A. Rookus (5 shared papers)K van der Kooy (1 shared paper)Jan D. van Gool (1 shared paper)Curt W. Burger (1 shared paper)Helen Klip (1 shared paper)Sabine Siesling (10 shared papers)M. Heins (8 shared papers)
Journals
Breast Cancer Research and Treatment (4 papers)The Breast (3 papers)European Journal of Cancer (2 papers)Annals of Oncology (2 papers)European Journal of Epidemiology (1 paper)
Partner nations
NetherlandsUnited StatesGermany

In The Last Decade

Janneke Verloop

28 papers receiving 811 citations

Peers

Janneke Verloop
Comparison fields: 5 of 97
  • Urology 70
  • Oncology 278
  • Health, Toxicology and Mutagenesis 120
  • Cancer Research 113
  • Pediatrics, Perinatology and Child Health 90
Replace Martin Ahlgren with:
Martin Ahlgren Denmark
Barbara Benton United States
J.-C. van der Auwera Belgium
Ken Batai United States
Sabah M. Quraishi United States
Kathleen Herkommer Germany
Marlen Keimling Germany
Ilonka Evans United States
Olayiwola B. Shittu Nigeria
Ardalan E. Ahmad Canada
Janneke Verloop relative to Martin Ahlgren Denmark Martin Ahlgren's profile →
Citations per field
00.5×5×10×15×20.3×
Martin Ahlgren · 1×
Citations per year

Countries citing papers authored by Janneke Verloop

Since Specialization
Citations

This map shows the geographic impact of Janneke Verloop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janneke Verloop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janneke Verloop more than expected).

Fields of papers citing papers by Janneke Verloop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janneke Verloop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janneke Verloop. The network helps show where Janneke Verloop may publish in the future.

Co-authors

The 25 scholars most cited alongside Janneke Verloop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Janneke Verloop Line = papers co-authored together Janneke Verloop links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study
The Lancet ·Helen Klip, Janneke Verloop, Jan D. van Gool, Marlies ETA Koster, Curt W. Burger, Flora E. van Leeuwen
2002214
2
Physical Activity and Breast Cancer Risk in Women Aged 20-54 Years
JNCI Journal of the National Cancer Institute ·Janneke Verloop, Matti A. Rookus, K van der Kooy, Flora E. van Leeuwen
2000164
3
Cancer risk in DES daughters
Cancer Causes & Control ·Janneke Verloop, Flora E. van Leeuwen, Theo J.M. Helmerhorst, Hester H. van Boven, Matti A. Rookus
201071
4
Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study
Journal of Hematology & Oncology ·Anouk H. Eijkelboom, Linda de Munck, Marie-Jeanne T. F. D. Vrancken Peeters, Mireille J. M. Broeders, Luc J. A. Strobbe, Monique E.M.M. Bos, Marjanka K. Schmidt, Cristina Guerrero Páez, Marjolein L. Smidt, Maud Bessems, Janneke Verloop, Sabine C. Linn, Marc B I Lobbes, Aafke H. Honkoop, Desirée H J G van den Bongard, Pieter J. Westenend, Jelle Wesseling, C. Willemien Menke‐van der Houven van Oordt, Vivianne C. G. Tjan‐Heijnen, Sabine Siesling
202171
5
Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit
Journal of Surgical Oncology ·A.C.M. van Bommel, P.E.R. Spronk, Marie-Jeanne T. F. D. Vrancken Peeters, Agnes Jager, Marc B. I. Lobbes, John H. Maduro, Marc A.M. Mureau, K. Schreuder, Carolien H. Smorenburg, Janneke Verloop, Pieter J. Westenend, Michel W.J.M. Wouters, Sabine Siesling, V.C.G. Tjan - Heijnen, Thijs van Dalen, (unknown)
201669
6
The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors
Breast Cancer Research and Treatment ·Kelly M. de Ligt, M. Heins, Janneke Verloop, Nicole P. M. Ezendam, Carolien H. Smorenburg, Joke C. Korevaar, Sabine Siesling
201952
7
De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study
The Lancet Oncology ·Sabine R. de Wild, Linda de Munck, Janine M. Simons, Janneke Verloop, Thijs van Dalen, Paula H.M. Elkhuizen, Ruud Houben, A. Elise van Leeuwen, Sabine C. Linn, Ruud M. Pijnappel, Philip Poortmans, Luc J. A. Strobbe, Jelle Wesseling, Adri C. Voogd, Liesbeth Boersma
202242
8
Patient-reported health problems and healthcare use after treatment for early-stage breast cancer
The Breast ·Kelly M. de Ligt, M. Heins, Janneke Verloop, Carolien H. Smorenburg, Joke C. Korevaar, Sabine Siesling
201929
9
Adverse health effects after breast cancer up to 14 years after diagnosis
The Breast ·M. Heins, Kelly M. de Ligt, Janneke Verloop, Sabine Siesling, Joke C. Korevaar, Annette J. Berendsen, Daan Brandenbarg, Anneriet E. Dassen, Agnes Jager, Jacqueline G. Hugtenburg, Gerda van der Weele
202129
10
Impact on Quality of Documentation and Workload of the Introduction of a National Information Standard for Tumor Board Reporting
JCO Clinical Cancer Informatics ·Kees C.W.J. Ebben, Melle Sieswerda, Ernest J. T. Luiten, Joan B. Heijns, Carmen C. van der Pol, Maud Bessems, Aafke H. Honkoop, Mathijs P. Hendriks, Janneke Verloop, Xander Verbeek
202014
11
Radiotherapy after primary CHEMotherapy (RAPCHEM): Practice variation in a Dutch registration study (BOOG 2010-03)
Radiotherapy and Oncology ·Liesbeth Boersma, Janneke Verloop, Adri C. Voogd, Paula H.M. Elkhuizen, Ruud Houben, A. Elise van Leeuwen, Sabine C. Linn, Linda de Munck, Ruud M. Pijnappel, Luc J. A. Strobbe, Thijs van Dalen, Jelle Wesseling, Philip Poortmans
202013
12
The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands
Annals of Oncology ·Anne Kuijer, Janneke Verloop, Otto Visser, Gabe S. Sonke, Agnes Jager, Carla H. van Gils, T van Dalen, S. G. Elias
201713
13
Varying severities of symptoms underline the relevance of personalized follow-up care in breast cancer survivors: latent class cluster analyses in a cross-sectional cohort
Supportive Care in Cancer ·Kelly M. de Ligt, Belle H. de Rooij, Iris Walraven, M. Heins, Janneke Verloop, Sabine Siesling, Joke C. Korevaar, Lonneke V. van de Poll‐Franse
202211
14
Prognosis of pregnancy-associated breast cancer: inferior outcome in patients diagnosed during second and third gestational trimesters and lactation
Breast Cancer Research and Treatment ·Britt B.M. Suelmann, Carsten F J Bakhuis, Carmen van Dooijeweert, Janneke Verloop, Ronald P. Zweemer, Sabine C. Linn, Elsken van der Wall, P. J. van Diest
20227
15
Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level
Breast Cancer Research and Treatment ·Admar Verschoor, Anne Kuijer, Janneke Verloop, Carla H. van Gils, Gabe S. Sonke, Agnes Jager, Thijs van Dalen, S. G. Elias
20167
16
Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters
Gynecologic Oncology ·Janneke Verloop, Flora E. van Leeuwen, Th.J.M. Helmerhorst, Inge M.C.M. de Kok, E.J.M. van Erp, Hester H. van Boven, Matti A. Rookus
20165
17
Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study
Radiology ·Max A. A. Ragusi, Bas H. M. van der Velden, Carla Meeuwis, Eric Tetteroo, Emile G. Coerkamp, Thiemo J. A. van Nijnatten, Frits H. Jansen, Elian J. M. Wolters‐van der Ben, Lisa M. Jongen, Fleur van Raamt, Monique D. Dorrius, Janneke Verloop, Max A. Viergever, Ruud M. Pijnappel, Sjoerd G. Elias, Kenneth G. A. Gilhuijs
20235
18
Opportunities and obstacles in linking large health care registries: the primary secondary cancer care registry - breast cancer
BMC Medical Research Methodology ·M. Heins, Kelly M. de Ligt, Janneke Verloop, Sabine Siesling, Joke C. Korevaar
20224
19
Cancer risk after in utero exposure to diethylstilbestrol
European Journal of Epidemiology ·Naomi B. Boekel, Janneke Verloop, Hester H. van Boven, E.J.M. van Erp, Lieske H. Schrijver, Matti A. Rookus, Flora E. van Leeuwen
20252
20
Patient-reported health problems and health care use after treatment for early breast cancer
Annals of Oncology ·Kelly M. de Ligt, M. Heins, Janneke Verloop, Carolien H. Smorenburg, Joke C. Korevaar, Sabine Siesling
20192

About Janneke Verloop

Janneke Verloop is a scholar working on Oncology, Cancer Research, Health, Toxicology and Mutagenesis, Radiology, Nuclear Medicine and Imaging and Political Science and International Relations, having authored 29 papers that have together received 832 indexed citations. Recurring topics across this work include Cancer Risks and Factors (6 papers), Cancer survivorship and care (6 papers), Breast Cancer Treatment Studies (6 papers), Global Cancer Incidence and Screening (3 papers), Effects and risks of endocrine disrupting chemicals (2 papers), Estrogen and related hormone effects (1 paper), MRI in cancer diagnosis (1 paper) and COVID-19 and healthcare impacts (1 paper). The work is most often cited by research in Urology (70 citations), Oncology (278 citations), Health, Toxicology and Mutagenesis (120 citations), Cancer Research (113 citations) and Pediatrics, Perinatology and Child Health (90 citations). Janneke Verloop has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Flora E. van Leeuwen, Matti A. Rookus, K van der Kooy, Jan D. van Gool, Curt W. Burger, Helen Klip, Sabine Siesling, M. Heins, Joke C. Korevaar and Kelly M. de Ligt. Their work appears in journals such as Breast Cancer Research and Treatment, The Breast, European Journal of Cancer, Annals of Oncology and European Journal of Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin AhlgrenBreakdown of academic impact, for papers by Barbara BentonBreakdown of academic impact, for papers by J.-C. van der AuweraBreakdown of academic impact, for papers by Ken BataiBreakdown of academic impact, for papers by Sabah M. QuraishiBreakdown of academic impact, for papers by Kathleen HerkommerBreakdown of academic impact, for papers by Marlen KeimlingBreakdown of academic impact, for papers by Ilonka EvansBreakdown of academic impact, for papers by Olayiwola B. ShittuBreakdown of academic impact, for papers by Ardalan E. Ahmad